Skip to main content

MoneyWorks4Me

Rubra Medicaments - Quaterly Results

07 Nov 2023 Evaluate
The sales is pegged at Rs. 2.90 millions for the September 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 3.60 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 2777.78% to Rs. 2.59  millions  from Rs. 0.09 millions in previous same quarter.Operating profit for the quarter ended September 2023 rose to 2.60 millions as compared to 0.09 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 2.90 3.60 -19.44 4.90 8.70 -43.68 11.60 20.11 -42.32
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01 100.00
PBIDT 2.60 0.09 2788.89 2.08 0.31 570.97 -0.78 -0.21 271.43
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.60 0.09 2788.89 2.08 0.31 570.97 -0.78 -0.21 271.43
Depreciation 0.02 0.00 0.00 0.04 0.00 0.00 0.03 0.02 50.00
PBT 2.58 0.09 2766.67 2.04 0.31 558.06 -0.81 -0.23 252.17
TAX -0.01 0.00 0.00 -0.01 0.08 -112.50 -0.02 0.14 -114.29
Deferred Tax -0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00
PAT 2.59 0.09 2777.78 2.05 0.23 791.30 -0.79 -0.37 113.51
Equity 54.68 54.68 0.00 54.68 54.68 0.00 54.68 54.68 0.00
PBIDTM(%) 89.66 2.50 3486.21 42.45 3.56 1091.32 -6.72 -1.04 543.89
Peers
Company Name CMP
Redington 358.60
Adani Enterprises 2736.00
Amrapali Industries 34.77
Maxgrow India 178.35
Rashi Peripheral 697.90
View more..